Osteoporosis affects 10 million people in the United States, the majority of them women. Romosozumab is a new type of medication for treating osteoporosis that offers another treatment option for some women after menopause.
Many women going through menopause experience symptoms of depression. Hormone therapy may help some women avoid depression, but carries an increased risk of blood clots or stroke. A woman should talk with her doctor and carefully evaluate of the risks and benefits of hormone therapy compared to other treatments for depression.
According to a recent study, there may be a connection between diet and age at menopause. Foods like legumes and oily fish appeared to delay the start of menopause, while refined pasta and rice were associated with an earlier start.
In its early stages, osteoporosis has no symptoms but causes millions of bone fractures every year, often resulting in loss of function and, disability and even death from the complications of the fracture. There are effective medications to prevent osteoporosis, but they can have serious (though rare) side effects. It’s best to talk discuss with your doctor to understand all your options and make an informed decision on how to best protect your bones.
According to conventional medical wisdom, menopause-related hot flashes fade away after six to 24 months. Not so, says a new study of women going through menopause. Hot flashes and related night sweats last, on average, for about seven years and may go on for 11 years or more. The new estimates of the duration of these symptoms come from the Study of Women’s Health Across the Nation (SWAN), a long-term study of women of different races and ethnicities who are in the menopausal transition. The “reality check” the SWAN study provides on hot flashes should encourage women to talk with a doctor about treatment options. These range from estrogen-based hormone therapy to other medications and self-help measures.